Company profile: Progeny Genetics
1.1 - Company Overview
Company description
- Provider of genotype management and laboratory information management software for leading biomedical concerns in 80+ countries. Offers configurable sample inventory, barcoding, custom workflows, and chain-of-custody tracking, plus clinical tools for family history, pedigree drawing, risk assessment, genetic test ordering, high-risk triage, and EMR integration.
Products and services
- Progeny Clinical: A model-driven clinical platform that manages family history, quantifies risk, and guides treatment, with pedigree drawing, risk assessment models, and genetic test ordering
- Progeny Laboratory Information Management System Software: A custom-configurable laboratory system that manages samples via inventory control, barcode generation and recording, custom workflows, and chain-of-custody tracking
- High Risk Triage Screening Tools: Questionnaire-based instruments that identify high-risk breast, colorectal, and other cancer patients using online questionnaires and risk models for triage
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Progeny Genetics
Bio-Optronics
HQ: United States
Website
- Description: Provider of healthcare information technology software focused on workflow optimization for healthcare organizations, offering Clinical Conductor CTMS with tools for patient recruitment, budgeting, billing, reporting, and participant engagement, integrated with other platforms for enhanced data quality and compliance; CCText two-way messaging for decentralized trial communications; and CCPay real-time participant payment reimbursements with analytics and caregiver support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio-Optronics company profile →
Academia.edu
HQ: United States
Website
- Description: Provider of the largest and fastest-growing platform for sharing academic research, enabling academics to share research papers and aiming to accelerate and democratize academic research. Over 150 million academics have signed up, adding 25 million papers, with more than 100,000 people joining each day.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Academia.edu company profile →
Chemos
HQ: Germany
Website
- Description: Provider of ready-to-use solutions for laboratories and the chemical industry, offering raw materials for organic synthesis, active ingredients for the pharmaceutical and food industries, and various catalysts and crosslinkers; also provides manual filling lines for solid and liquid.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chemos company profile →
ProofPilot
HQ: United States
Website
- Description: Provider of a clinical experience platform designed to streamline recruitment, engagement, and retention for clinical study stakeholders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProofPilot company profile →
Ampersand Biomedicines
HQ: United States
Website
- Description: Provider of programmable medicines and platforms that precisely target disease sites, including AND-Body Therapeutics for disease-specific precision and modification; the AND-Platform, a computational and experimental system enabled by a proprietary Address Map; the Opportunity Atlas for identifying localized targets; and enhanced biologic generation via AbCheck’s antibody discovery technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ampersand Biomedicines company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Progeny Genetics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Progeny Genetics
2.2 - Growth funds investing in similar companies to Progeny Genetics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Progeny Genetics
4.2 - Public trading comparable groups for Progeny Genetics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →